Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus
Clinical trial NCT04310215 · COMPLETED
Trial details
- NCT number
- NCT04310215
- Sponsor
- Hyundai Bioland Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-03
- Primary completion
- 2022-06-13
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.